Originally published as JCO Early Release 10.1200/JCO.2006.08.8575 on October 10 2006
Journal of Clinical Oncology, Vol 24, No 31 (November 1), 2006: pp. 5091-5097
© 2006 American Society of Clinical Oncology.
American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting
James L. Khatcheressian,
Antonio C. Wolff,
Thomas J. Smith,
Eva Grunfeld,
Hyman B. Muss,
Victor G. Vogel,
Francine Halberg,
Mark R. Somerfield,
Nancy E. Davidson
From the Virginia Commonwealth University/Massey Cancer Center, Richmond, VA; Johns Hopkins Hospital, Sidney Kimmel Cancer Center, Baltimore, MD; Marin Cancer Institute, Marin General Hospital, Greenbrae, CA; University of Vermont, Burlington, VT; Magee-Womens Hospital of the University of Pittsburgh Medical Center, Pittsburgh, PA; and Dalhousie University, Halifax, Nova Scotia, Canada
Address reprint requests to American Society of Clinical Oncology, 1900 Duke St, Suite 200, Alexandria, VA 22314; e-mail: guidelines{at}asco.org
Purpose To update the 1999 American Society of Clinical Oncology (ASCO) guideline on breast cancer follow-up and management in the adjuvant setting.
Methods An ASCO Expert Panel reviewed pertinent information from the literature through March 2006. More weight was given to studies that tested a hypothesis directly relating testing to one of the primary outcomes in a randomized design.
Results The evidence supports regular history, physical examination, and mammography as the cornerstone of appropriate breast cancer follow-up. All patients should have a careful history and physical examination performed by a physician experienced in the surveillance of cancer patients and in breast examination. Examinations should be performed every 3 to 6 months for the first 3 years, every 6 to 12 months for years 4 and 5, and annually thereafter. For those who have undergone breast-conserving surgery, a post-treatment mammogram should be obtained 1 year after the initial mammogram and at least 6 months after completion of radiation therapy. Thereafter, unless otherwise indicated, a yearly mammographic evaluation should be performed. Patients at high risk for familial breast cancer syndromes should be referred for genetic counseling. The use of CBCs, chemistry panels, bone scans, chest radiographs, liver ultrasounds, computed tomography scans, [18F]fluorodeoxyglucosepositron emission tomography scanning, magnetic resonance imaging, or tumor markers (carcinoembryonic antigen, CA 15-3, and CA 27.29) is not recommended for routine breast cancer follow-up in an otherwise asymptomatic patient with no specific findings on clinical examination.
Conclusion Careful history taking, physical examination, and regular mammography are recommended for appropriate detection of breast cancer recurrence.
published online ahead of print at www.jco.org on October 10, 2006.
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Zakhireh, B. Fowble, and L. J. Esserman
Application of Screening Principles to the Reconstructed Breast
J. Clin. Oncol.,
January 1, 2010;
28(1):
173 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Beslija, J. Bonneterre, H. J. Burstein, V. Cocquyt, M. Gnant, V. Heinemann, J. Jassem, W. J. Kostler, M. Krainer, S. Menard, et al.
Third consensus on medical treatment of metastatic breast cancer
Ann. Onc.,
November 1, 2009;
20(11):
1771 - 1785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Houssami, S. Ciatto, F. Martinelli, R. Bonardi, and S. W. Duffy
Early detection of second breast cancers improves prognosis in breast cancer survivors
Ann. Onc.,
September 1, 2009;
20(9):
1505 - 1510.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. E. Del Giudice, E. Grunfeld, B. J. Harvey, E. Piliotis, and S. Verma
Primary Care Physicians' Views of Routine Follow-Up Care of Cancer Survivors
J. Clin. Oncol.,
July 10, 2009;
27(20):
3338 - 3345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. PERRONE, V. ALTOMARE, M. ZAGAMI, E. VULCANO, L. MUZII, C. BATTISTA, C. RABITTI, and A. O. MUDA
Breast-like Vulvar Lesion with Concurrent Breast Cancer: A Case Report and Critical Literature Review
In Vivo,
July 1, 2009;
23(4):
629 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Nekhlyudov, L. A. Habel, N. S. Achacoso, I. Jung, R. Haque, L. C. Collins, S. J. Schnitt, C. P. Quesenberry Jr, and S. W. Fletcher
Adherence to Long-Term Surveillance Mammography Among Women With Ductal Carcinoma In Situ Treated With Breast-Conserving Surgery
J. Clin. Oncol.,
July 1, 2009;
27(19):
3211 - 3216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Guarneri and P. Conte
Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy
Oncologist,
July 1, 2009;
14(7):
645 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. L. McArthur, K. A. Gelmon, I. A. Olivotto, C. H. Speers, S. L. Ellard, S. E. O'Reilly, and H. F. Kennecke
Effectiveness of a Letter Notification Program for Women With Early-Stage Breast Cancer Eligible for Extended Adjuvant Letrozole
J. Clin. Oncol.,
March 20, 2009;
27(9):
1388 - 1393.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. F. Snyder, K. D. Frick, M. E. Kantsiper, K. S. Peairs, R. J. Herbert, A. L. Blackford, A. C. Wolff, and C. C. Earle
Prevention, Screening, and Surveillance Care for Breast Cancer Survivors Compared With Controls: Changes from 1998 to 2002
J. Clin. Oncol.,
March 1, 2009;
27(7):
1054 - 1061.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A Montgomery
Follow-up by telephone after treatment for breast cancer
BMJ,
January 14, 2009;
338(jan14_2):
a2753 - a2753.
[Full Text]
|
 |
|

|
 |

|
 |
 
C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Clin. Chem.,
December 1, 2008;
54(12):
e11 - e79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Henkel, R. A. Cooper, K. A. Ward, D. Bova, and K. Yao
Malignant-Appearing Microcalcifications at the Lumpectomy Site with the Use of FloSeal Hemostatic Sealant
Am. J. Roentgenol.,
November 1, 2008;
191(5):
1371 - 1373.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Smedira, R. J. Patrick, L. A. Rybicki, and J. P. Crowe
Integrating Medical Breast Specialists Into the Traditional Breast Center Practice Model: A Review of 11 Years of Experience
Arch Intern Med,
October 13, 2008;
168(18):
2042 - 2045.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-P. P. Tran and J. L. Grabinski
Chemotherapy for Early-Stage Breast Cancer: A Paradigm in Flux
Journal of Pharmacy Practice,
February 1, 2008;
21(1):
46 - 56.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Kim, E.-K. Kim, J. Y. Kwak, B.-W. Park, S.-I. Kim, J. Sohn, and K. K. Oh
Role of Sonography in the Detection of Contralateral Metachronous Breast Cancer in an Asian Population
Am. J. Roentgenol.,
February 1, 2008;
190(2):
476 - 480.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Harris, H. Fritsche, R. Mennel, L. Norton, P. Ravdin, S. Taube, M. R. Somerfield, D. F. Hayes, and R. C. Bast Jr
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
J. Clin. Oncol.,
November 20, 2007;
25(33):
5287 - 5312.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
J. Oncol. Pract,
November 1, 2007;
3(6):
336 - 339.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Kulasingam and E. P. Diamandis
Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines: A Mine for Biomarkers and Therapeutic Targets
Mol. Cell. Proteomics,
November 1, 2007;
6(11):
1997 - 2011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Brewster, K.-A. Do, P. A. Thompson, K. M. Hahn, A. A. Sahin, Y. Cao, M. M. Stewart, J. L. Murray, G. N. Hortobagyi, and M. L. Bondy
Relationship Between Epidemiologic Risk Factors and Breast Cancer Recurrence
J. Clin. Oncol.,
October 1, 2007;
25(28):
4438 - 4444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Tondini, P Fenaroli, and R Labianca
Breast cancer follow-up: just a burden, or much more?
Ann. Onc.,
September 1, 2007;
18(9):
1431 - 1432.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Lash, M. P. Fox, D. S.M. Buist, F. Wei, T. S. Field, F. J. Frost, A. M. Geiger, V. P. Quinn, M. U. Yood, and R. A. Silliman
Mammography Surveillance and Mortality in Older Breast Cancer Survivors
J. Clin. Oncol.,
July 20, 2007;
25(21):
3001 - 3006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Mandelblatt
To Screen or Not to Screen Older Women for Breast Cancer: A New Twist on an Old Question or Will We Ever Invest in Getting the Answers?
J. Clin. Oncol.,
July 20, 2007;
25(21):
2991 - 2992.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Goldhirsch, W. C. Wood, R. D. Gelber, A. S. Coates, B. Thurlimann, H. -J. Senn, and Panel Members
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007
Ann. Onc.,
July 1, 2007;
18(7):
1133 - 1144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. F. Hayes
Follow-up of Patients with Early Breast Cancer
N. Engl. J. Med.,
June 14, 2007;
356(24):
2505 - 2513.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. L. Keating, M. B. Landrum, E. Guadagnoli, E. P. Winer, and J. Z. Ayanian
Surveillance Testing Among Survivors of Early-Stage Breast Cancer
J. Clin. Oncol.,
March 20, 2007;
25(9):
1074 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Breast Cancer Does Not Need High-Tech Follow-Up
Journal Watch Women's Health,
December 14, 2006;
2006(1214):
1 - 1.
[Full Text]
|
 |
|
|